Patient Outcomes following Artificial Urinary Sphincter Placement in Male Patients

Overview

About this study

The purpose of this study is to create a Mayo Clinic AUS research database with follow-up through 4 months.  To eventually evaluate other risk factors for AUS complications, including prior treatments, comorbidities and obesity.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Males who have developed stress urinary incontinence (SUI) following either radical prostatectomy and/or radiation therapy for prostate cancer  
  • Males who have developed SUI following transurethral resection for benign prostate enlargement. 
  • All patients must be otherwise candidates for the artificial Urinary Sphincter (AUS) 
  • Must pass preoperative evaluation and have their artificial Urinary Sphincter (AUS) at Mayo Clinic

Exclusion Criteria:

  • Male patients will be included in the database since the number of female artificial urinary sphincter cases is exceedingly rare with less than one/5 years
  • Subjects who refuse access to their records for research

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Daniel Elliott, M.D.

Closed for enrollment

Contact information:

Daniel Elliott M.D.

127or7746419

Elliott.Daniel@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available